!["Computer-Aided Diagnosis provided by Al needs to gain trust from doctors" "Computer-Aided Diagnosis provided by Al needs to gain trust from doctors"](https://cdn.magzter.com/1444374281/1698667086/articles/mGJ5BRkJf1698844795221/COMPUTERAIDED-DIAGNOSIS-PROVIDED-BY-AL-NEEDS-TO-GAIN-TRUST-FROM-DOCTORS.jpg)
How will ITRI’s Point-of-Care AI-DR system address critical healthcare needs related to diabetic retinopathy and diabetic macular edema?
Currently, most medical imaging AI-assisted diagnosis systems are used to assist doctors in their respective specialties, such as AI assisting radiologists in X-rays and CT scans, AI aiding pathologists in pathology images, and AI supporting internal medicine doctors in ultrasound images. The purpose of the colour fundus image AI-assisted diagnosis and detection system is not to assist ophthalmologists in diagnosing eye diseases but to provide diabetes care physicians (e.g., those in metabolism and family medicine) with the capability to diagnose retinal diseases. Diabetic patients can have fundus examinations during their regular checkups without the need to be referred to ophthalmology, saving them time and registration fees. This onestop service speeds up the process of fundus examinations, leading to the early detection, early treatment, and the prevention of retinal diseases, which can cause significant burdens on families.
From a business perspective, what opportunities and challenges do you see in the adoption and commercialIn November 2022, The Industrial Technology Research Institute (ITRI), Taiwan’s prominent high-tech research institution, launched Point-of Care AI-DR, the first AI-assisted system integrated into commonly used handheld and desktop fundus cameras in healthcare settings for diabetic retinopathy (DR) and diabetic macular edema (DME) detection. Dr Lee Ya-wen, Technical Manager, ICL, ITRI sheds more light on ITRI’s Point-of-Care AI-DR system, opportunities and challenges of AI-assisted diagnostic systems etc. Edited excerpts:isation of AI-assisted diagnostic systems like Point-of-Care AI-DR in the global healthcare market?
هذه القصة مأخوذة من طبعة November 2023 من BioSpectrum Asia.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة November 2023 من BioSpectrum Asia.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
![Prof. Christian Wolfrum to join NTU as Deputy President and Provost Prof. Christian Wolfrum to join NTU as Deputy President and Provost](https://reseuro.magzter.com/100x125/articles/11639/1979239/aFQSj2cXo1738327652897/PROF-CHRISTIAN-WOLFRUM-TO-JOIN-NTU-AS-DEPUTY-PRESIDENT-AND-PROVOST.jpg)
Prof. Christian Wolfrum to join NTU as Deputy President and Provost
Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.
![Japan suggests addition of PVA into drugs for strong antitumour activity Japan suggests addition of PVA into drugs for strong antitumour activity](https://reseuro.magzter.com/100x125/articles/11639/1979239/L7QBK8c9t1738327954522/JAPAN-SUGGESTS-ADDITION-OF-PVA-INTO-DRUGS-FOR-STRONG-ANTITUMOUR-ACTIVITY.jpg)
Japan suggests addition of PVA into drugs for strong antitumour activity
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.
!["Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly" "Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"](https://reseuro.magzter.com/100x125/articles/11639/1979239/Bh4IoWqD71738326641256/DEMAND-FOR-SKILLED-MEDTECH-PROFESSIONALS-IN-THE-ASIA-PACIFIC-REGION-IS-GROWING-RAPIDLY.jpg)
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.
![BeiGene names Giancarlo Benelli as Head of Europe biz BeiGene names Giancarlo Benelli as Head of Europe biz](https://reseuro.magzter.com/100x125/articles/11639/1979239/dtWtyXs321738327727847/BEIGENE-NAMES-GIANCARLO-BENELLI-AS-HEAD-OF-EUROPE-BIZ.jpg)
BeiGene names Giancarlo Benelli as Head of Europe biz
BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.
![Korea develops innovative injectable adhesive hydrogel for bone regeneration Korea develops innovative injectable adhesive hydrogel for bone regeneration](https://reseuro.magzter.com/100x125/articles/11639/1979239/3Ds0USfx91738327790862/KOREA-DEVELOPS-INNOVATIVE-INJECTABLE-ADHESIVE-HYDROGEL-FOR-BONE-REGENERATION.jpg)
Korea develops innovative injectable adhesive hydrogel for bone regeneration
A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.
![When Clinical Trials Suffer From 'Complicated' Interactions When Clinical Trials Suffer From 'Complicated' Interactions](https://reseuro.magzter.com/100x125/articles/11639/1979239/NXkS_2pHM1738327122349/WHEN-CLINICAL-TRIALS-SUFFER-FROM-COMPLICATED-INTERACTIONS.jpg)
When Clinical Trials Suffer From 'Complicated' Interactions
Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.
![Dr Krishna M Ella receives prestigious INSA India fellowship Dr Krishna M Ella receives prestigious INSA India fellowship](https://reseuro.magzter.com/100x125/articles/11639/1979239/ewbWvQ-3l1738327520276/DR-KRISHNA-M-ELLA-RECEIVES-PRESTIGIOUS-INSA-INDIA-FELLOWSHIP.jpg)
Dr Krishna M Ella receives prestigious INSA India fellowship
Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.
![Bruker launches infrared imaging microscope for pharma and life science research Bruker launches infrared imaging microscope for pharma and life science research](https://reseuro.magzter.com/100x125/articles/11639/1979239/AOv9T23_N1738328062423/BRUKER-LAUNCHES-INFRARED-IMAGING-MICROSCOPE-FOR-PHARMA-AND-LIFE-SCIENCE-RESEARCH.jpg)
Bruker launches infrared imaging microscope for pharma and life science research
US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.
![Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities](https://reseuro.magzter.com/100x125/articles/11639/1979239/vrAMheQwA1738328031280/QIAGEN-INCREASES-QIACUITY-DIGITAL-PCR-HIGHORDER-MULTIPLEXING-CAPABILITIES.jpg)
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.
![Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers](https://reseuro.magzter.com/100x125/articles/11639/1979239/5sZt4mdv41738328195356/REPLIGEN-UNVEILS-ADVANCED-UVBASED-VARIABLE-PATHLENGTH-TECHNOLOGY-SYSTEM-FOR-BIOPHARMA-MANUFACTURERS.jpg)
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.